Skip to main content
Clinical Trials/NCT01828424
NCT01828424
Completed
Not Applicable

Prediction of Postoperative Pain by Measuring Nociception at the End of Surgery

Benno Rehberg-Klug1 site in 1 country100 target enrollmentJune 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Postoperative Pain
Sponsor
Benno Rehberg-Klug
Enrollment
100
Locations
1
Primary Endpoint
pain upon arrival in the recovery room
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

There is a large variability of postoperative pain intensity and of the drug doses necessary to alleviate this pain. The investigators hypothesis is that a measurement of nociception at the end of surgery, using either the RIII reflex threshold, measures of heart rate variability or the pupil dilatation reflex measured by pupillometry, in relation to the doses of opioids used intraoperatively will yield a prediction of postoperative pain.

Detailed Description

Acute postoperative pain needs to be alleviated quickly to avoid sensitization in the postoperative period, since sensitization can lead to pain chronification. Severe acute postoperative pain is the most important risk factor in the development of persistent postoperative pain. Unfortunately, the dose of opioids necessary to alleviate postoperative pain is highly variable, even between patients having been exposed to the same surgical procedure. Anesthesiologists usually try to prevent immediate postoperative pain by adjusting analgesic dosing at the end of surgery to the perceived need of analgesia. However, this approach is limited by the problem of respiratory depression induced by a too large dose of opiate analgesics. Studies have shown that despite these attempts many patients awake with moderate to severe pain. A means of predicting immediate postoperative pain after surgery and the response to opiate analgesics would therefore be highly desirable. Many studies have tried to reveal predictive factors which can be evaluated before the start of the surgery, but these can explain only about 50% of the observed variability in postoperative pain intensity. A different approach may be the evaluation of intraoperative nociception at the end of surgery to directly guide appropriate analgesia before the patient has regained consciousness. Measuring reflex pupil dilation after a standardized electrical stimulus is one method to measure opioid effect intra-operatively. This parameter may reflect opioid sensitivity, but not pain sensitivity. The primary objective of this study is the evaluation of measures of nociception such as the pupillary dilation reflex or heart rate variability on acute pain after surgery. In addition, pupillary dilation reflex and heart rate variability will be evaluated in their predictive performance of blood pressure and heart rate changes due to intubation. The study is designed as a single centre, observational, descriptive study.

Registry
clinicaltrials.gov
Start Date
June 2013
End Date
June 2017
Last Updated
6 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Benno Rehberg-Klug
Responsible Party
Sponsor Investigator
Principal Investigator

Benno Rehberg-Klug

médecin adjoint agrégé

University Hospital, Geneva

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiology (ASA) physical status less than 3
  • Able to read and understand the information sheet and to sign and date the consent form
  • Being scheduled for elective gynaecological intraperitoneal surgery (laparoscopy, laparoscopic hysterectomy, vaginal hysterectomy, abdominal hysterectomy) under general anesthesia

Exclusion Criteria

  • Regional anesthesia (epidural analgesia, multi-orifice wound catheter, or transversus abdominis plane block) used for postoperative analgesia
  • Surgery performed under regional anesthesia
  • Contraindication to a general anesthesia using propofol and sufentanil (e.g. necessity for rapid sequence induction)
  • BMI \>35 (limit of the equations used in the target controlled infusion device)
  • Severe renal insufficiency precluding use of morphine (GFR\<30 ml/min)

Outcomes

Primary Outcomes

pain upon arrival in the recovery room

Time Frame: 20 minutes

presence or absence of pain reported by the patient upon arrival in the recovery room

opioid effect

Time Frame: 20 minutes

Opioid effect as defined on a scale of -1 to +1: "+1" =pain intensity \>3 upon arrival in the recovery room, necessitating treatment "0" = pain intensity \<=3 upon arrival in the recovery, no respiratory depression at the time of stop of the sufentanil infusion (respiratory frequency immediately \>8/min) "-1" = pain intensity \<=3 upon arrival in the recovery, time to a steady respiratory frequency of \>8/min is less than 20 min (=mean of all patients) from time of stop of the sufentanil infusion. This outcome will be used as primary outcome if less than 20% of patients report a pain intensity of \>3 upon arrival in the recovery room.

Secondary Outcomes

  • respiratory depression(20 minutes)
  • systolic blood pressure increase after intubation(6 minutes)
  • mean pain intensity first 24h(24h)
  • heart rate increase after intubation(6 minutes)
  • cumulative morphine dose(24 hours)

Study Sites (1)

Loading locations...

Similar Trials